Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Study investigating VR treatment for chronic pain

May 18, 2022 Research and Development

AppliedVR and Kernel have partnered for a randomised study comparing the effect of AppliedVR’s FDA-authorised, VR-based program, RelieVRx, versus a …
News

More monkeypox cases detected in England

May 18, 2022 Research and Development

The UK Health Security Agency (UKHSA) says the risk presented by monkeypox to the public remains very low, though it …
News

SMC accepts chemotherapy-free VENCLYXTO for leukaemia treatment

May 11, 2022 Research and Development

The SMC has accepted venetoclax in combination with obinutuzumab, for use within NHS Scotland, as a first-line treatment for patients …
News

Europe’s first psychedelic drug trial clinic to open in London

May 11, 2022 Research and Development

British startup Clerkenwell Health aims to make the UK a global leader in psychedelic research and innovation, with Europe’s first …
News

Partnership researching genetics and treatments of long COVID

May 11, 2022 Research and Development

PrecisionLife Limited have announced a partnership with Sano Genetics, a genetic research platform enabling patients to participate in ethical research …
News

Ardena confirms spray drying upgrade and other capabilities at Spanish site

May 11, 2022 Research and Development

 
News

NIH launches clinical trial of vaccine for Epstein-Barr virus

May 9, 2022 Research and Development

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …
News

BLINCYTO approved in China for leukaemia treatment

May 4, 2022 Research and Development

The China National Medical Products Administration (NMPA) has granted conditional approval of BLINCYTO (blinatumomab), as an injection for the treatment …
News

Amphista Therapeutics and Bristol Myers Squibb partner for development of protein degradation therapeutics

May 4, 2022 Research and Development

Amphista and Bristol-Myers Squibb have announced a strategic collaboration and license agreement.Under the terms of the collaboration, BMS and Amphista …
News

Smartphone app could screen for Alzheimer’s disease

May 4, 2022 Research and Development

Researchers at the University of California San Diego have developed a smartphone app with the potential to screen for Alzheimer’s …
News

WHO announce upcoming updates on treatment of drug-resistant tuberculosis

May 4, 2022 Research and Development

A rapid communication released by WHO Global Tuberculosis Programme has announced upcoming updates to the guidance on the treatment of …
News

Quell Therapeutics and Cellistic collaborate to develop T-regulatory cell therapy platform

April 27, 2022 Research and Development

Quell Therapeutics and Cellistic have entered into a strategic collaboration for the co-development of an iPSC-derived Treg cell therapy platform. …
News

Gesynta Pharma receives orphan drug designation by FDA for systemic sclerosis

April 27, 2022 Research and Development

Orexo has announced that their partner, Gesynta Pharma has been granted Orphan Drug Designation by the FDA, for OX-MPI (GS248), …
News

Enhertu granted FDA Breakthrough Therapy Designation

April 27, 2022 Research and Development

AstraZeneca’s Enhertu® (fam-trastuzumab deruxtecan-nxki) has been granted breakthrough therapy designation in the US for adult patients with HER2-low metastatic breast …
News

Takeda Nuvaxovid COVID-19 vaccine approved in Japan

April 20, 2022 Research and Development

Takeda’s Nuvaxovid Intramuscular Injection (Nuvaxovid) has been approved by the Japan Mnistry of Health, Labour and Welfare (MHLW). This is …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025